COGT R&D Expenses
Cogent Biosciences Inc · R&D Expenses
COGT R&D Expenses
Latest reported$289.55Mperiod ending
COGT R&D Expenses ($6.85M → $289.55M)
Annual R&D Expenses
High-resolution chart · PNG
COGT r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 269,780,000 | |
| 232,658,000 | |
| 173,755,000 | |
| 121,627,000 | |
| 55,913,000 | |
| 72,648,000 | |
| 43,709,000 | |
| 38,285,000 | |
| 29,832,000 | |
| 21,992,000 | |
| 6,852,000 |